Ohio Gov. Mike DeWine signed an executive order on Jan. 5 banning anyone under the age of 18 from receiving gender-transition surgeries at any Ohio hospital or ambulatory surgical facility.
Category: Static
Mercy names 3 leaders to spearhead specialty service lines
Mercy, a multistate health system based in St. Louis, has selected three leaders as presidents of specialty service lines.
Supreme Court allows Idaho to reinstate abortion ban
After initial review, the Supreme Court has revived an Idaho abortion law that a federal trial judge partially blocked in 2022, NBC News reported Jan. 5.
GE HealthCare's newest acquisition
GE HealthCare will now use MIM Software technologies to further their innovation and AI-oriented patient-care mission.
Agilon Health CFO retiring
Tim Bensley, CFO of Austin, Texas-based Agilon Health, is retiring sometime in 2024.
Viewpoint: How hospitals may be violating inmate care rights
Many hospitals have a culture that too often neglects incarcerated patients’ rights and leads to worse outcomes, Dan Resnick, MD, an internal medicine resident at Atlanta-based Emory University School of Medicine, and Mark Spencer, MD, an internal medi…
AHA challenges HHS' web tracking rule
The American Hospital Association requested a Texas federal judge issue an expedited judgment in support of their legal opposition to a rule by the HHS that limits the utilization of third-party web technologies on sections of hospitals’ webpages.
Pictures don't cut it for medication safety: ISMP
Hospital pharmacy leaders should be vigilant about eradicating the syringe drawback method — and taking pictures during sterile compounding isn’t enough, according to Rita Jew, PharmD, president of the Institute for Safe Medication Practices.&nbs…
Hospital financial 'never events' need attention
There have been plenty of contentious payer negotiations in the last year as hospitals request increased pay rates to match inflation and cover services for the community while insurers seek slower rate growth after the pandemic.
4 Ozempic updates
Ozempic is facing increased competition from compounded versions and rival drugmakers, while potential side effects, including suicidal thoughts and hair loss, have spurred investigations into it and similar drugs.
